Los puntos clave no están disponibles para este artículo en este momento.
The aim of this study was to evaluate the response to rituximab (RTX) as treatment for lupus nephritis (LN) in a Latin American Lupus cohort.
Pimentel-Quiroz et al. (Wed,) studied this question.